查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829890

2025年穿戴式注射器全球市場報告

Wearable Injectors Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，穿戴式注射器市場快速擴張，市場規模從2024年的88.4億美元成長至2025年的98.4億美元，複合年成長率達11.3%。預測期內的成長可歸因於慢性病管理、患者便利性、技術進步以及人口老化。

穿戴式注射器市場規模預計在未來幾年內將快速成長，到2029年將達到172億美元，年複合成長率（CAGR）為15.0%。預測期內的成長主要由個人化醫療、遠端患者監護、藥物開發和慢性病管理推動。預測期內的主要趨勢包括生技藥品和大分子、雙腔穿戴式裝置、連網型設備以及貼片幫浦技術。

穿戴式注射器是一種專門的藥物輸送裝置，它附著在患者的身體上，在預定的時間內內皮下注射藥物。

這些穿戴式注射器主要分為兩種：體內注射器和體外注射器。體內注射器是直接佩戴在患者皮膚上的藥物輸送裝置，通常佩戴在腹部或腋下。它們應用於免疫腫瘤學、糖尿病和心血管疾病等多個醫療領域，並在醫院、診所和居家醫療等各種醫療環境中使用。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制價格上漲，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供穿戴式注射器市場統計數據，包括穿戴式注射器行業的全球市場規模、各地區市場佔有率、穿戴式注射器市場佔有率競爭對手、穿戴式注射器市場細分、市場趨勢和商機，以及您在穿戴式注射器行業取得成功所需的數據。本穿戴式注射器市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

我們預測未來五年該市場將成長15.0%，較先前預測略有下降0.2%。下降的主要原因是美國與其他國家之間的關稅影響。這種影響可能會直接波及美國，導致來自印度和墨西哥等主要地區的無針給藥裝置和藥筒組件供應鏈中斷，可能導致自主給藥生物製藥價格上漲。此外，由於互惠關稅以及不斷升級的貿易摩擦和限制，全球經濟和貿易將受到更廣泛的負面影響。

糖尿病、心血管疾病和癌症等慢性疾病的增加，對穿戴式注射器市場的成長貢獻巨大。例如，根據英國糖尿病協會（一家支持糖尿病患者的英國慈善機構）2023年4月的報告，英國約有430萬人被診斷為糖尿病。其中，約90%患有第2型糖尿病，約8%患有第1型糖尿病，其餘2%患有其他類型的糖尿病。慢性疾病患者的增加，推動了對治療解決方案的需求，從而推動了穿戴式注射器市場的擴張。

預計未來幾年，老齡人口的成長將成為穿戴式注射器市場擴張的驅動力。這類人群通常由65歲及以上的老年人組成，穿戴式注射器為他們提供了一種便捷的自我用藥方式，減少了頻繁就醫的需求，同時提高了患者獨立性和對治療計劃的依從性。例如，世界衛生組織（WHO）於2022年10月報告稱，到2030年，全球整體六分之一的人口將達到60歲或以上，並預測2050年老年人口將達到21億人。因此，老齡人口的成長是穿戴式注射器市場擴張的主要驅動力。

穿戴式注射器製造市場中的許多公司正專注於開發先進產品，例如體內注射器 (OBI)，以提高患者的便利性、改善對處方治療的依從性並滿足日益成長的自我管理生技藥品的需求。體內注射器 (OBI) 是一種穿戴式的藥物輸送裝置，旨在在特定時間內內皮下給藥，為需要大容量或定期注射的患者提供便利。例如，2024 年 2 月，美國化療Corherus Biosciences 推出了使用 LTS Sorel 穿戴式平台的先進藥物輸送裝置 UDENYCA。該裝置用於給藥聚Pegfilgrastim- cbqv，這是Pegfilgrastim的生物學名藥，用於降低化療後第二天發生發熱性中性粒細胞減少症的風險，發熱性中性粒細胞減少症是一種因感染疾病嗜中性白血球低下症。 OBI 確保準確的劑量和家庭管理的便利性，無需額外就診。

為了增加市場收益，穿戴式注射器市場的主要企業越來越注重推出創新的藥物輸送設備，例如 enFuse 注射器。 enFuse 注射器設計用於自我給藥大量藥物，為患者提供舒適和便利。例如，2023 年 9 月，美國醫療科技公司 Enable Injections, Inc. 獲得了美國食品藥物管理局(FDA) 的 enFuse 注射器核准。這款穿戴式注射器用於皮下注射 EMPAVELI，這是 Apellis Pharmaceuticals Inc. 在美國銷售的一種用於陣發性夜間血尿症(PNH) 成人的藥物。 enFuse 注射器是一種小型穿戴式設備，可最大限度地減少對患者日常生活的干擾並簡化自我給藥過程。它允許免持給藥，劑量最多為 25 毫升，適合在家中或臨床環境中使用。 FDA核准enFuse注射器為患者提供了更方便的給藥方式。

2023年6月，德國製藥公司LTS LOHMANN Therapie-Systeme AG以未揭露的金額收購了Eitan Medical旗下的穿戴式注射器Sorrel業務。此次收購預計將拓寬LTS LOHMANN Therapie-Systeme AG的藥物傳輸平台，並增強其在大分子和生技藥品領域的產品組合。 Eitan Medical Ltd.是一家以色列醫療設備製造商，以開發創新藥物輸送解決方案（包括穿戴式注射器）而聞名。

穿戴式注射器市場的主要企業包括安進公司 (Amgen Inc.)、碧迪公司 (Becton Dickinson and Company, BD)、Enable Injections LLC、Insulet Corporation、Ypsomed Holding AG、美敦力 MiniMed 公司、Tandem Diabetes Care 公司、Valeritas 公司、West Pharmaceutical 公司、S醫生PLC、United Therapeutics 公司、Buhler Motor GmbH、Debiotech SA、Cellnovo Group、EoFlow Co. Ltd.、CeQur SA、Haselmeier AG、強生公司、kaleo 公司、邁蘭公司、Nemera Development SA、F. Hoffmann-La Roche Ltd. 和 Zosano Pharma 公司。

2024年，穿戴式注射器市場最大的地區是北美。西歐是穿戴式注射器市場的第二大分析地區。穿戴式注射器市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美、中東和非洲。

穿戴式注射器市場報告涵蓋的國家包括澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、西班牙和加拿大

穿戴式注射器市場涵蓋體內和體外注射器等設備的銷售。此市場的價值為出廠價，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場中的產品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球穿戴式注射器：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球穿戴式注射器市場：成長率分析
  • 全球穿戴式注射器市場表現：規模與成長，2019-2024
  • 全球穿戴式注射器市場預測：規模與成長，2024-2029 年，2034 年
  • 全球穿戴式注射器：總目標市場（TAM）

第6章 市場細分

  • 全球穿戴式注射器市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 體內注射器
  • 離體注射器
  • 全球穿戴式注射器市場：按最終用戶、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 居家照護環境
  • 全球穿戴式注射器市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 免疫腫瘤學
  • 糖尿病
  • 心血管疾病
  • 其他用途
  • 全球穿戴式注射器市場：體內注射器細分（按類型）、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 基於補丁的注射器
  • 黏合劑注射器
  • 針頭注射器
  • 無針注射器
  • 全球穿戴式注射器市場：離體注射器細分（按類型）、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 帶式注射器
  • 手持式注射器
  • 夾式注射器

第7章 區域和國家分析

  • 全球穿戴式注射器市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球穿戴式注射器市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 穿戴式注射器市場：競爭格局
  • 穿戴式注射器市場：公司簡介
    • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company（BD）Overview, Products and Services, Strategy and Financial Analysis
    • Enable Injections LLC Overview, Products and Services, Strategy and Financial Analysis
    • Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Ypsomed Holding AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Medtronic MiniMed Inc.
  • Tandem Diabetes Care Inc.
  • Valeritas Inc.
  • West Pharmaceutical Services Inc.
  • Sensile Medical AG
  • Gerresheimer AG
  • Dexcom Inc.
  • Consort Medical plc
  • United Therapeutics Corporation
  • Buhler Motor GmbH
  • Debiotech SA
  • Cellnovo Group
  • EoFlow Co. Ltd.
  • CeQur SA
  • Haselmeier AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年穿戴式注射器市場：提供新機會的國家
  • 2029年穿戴式注射器市場：細分市場帶來新機會
  • 2029年穿戴式注射器市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r32863u

Wearable injectors are specialized drug delivery devices that affix to the patient's body during the subcutaneous administration of drugs over a predetermined duration.

These wearable injectors come in two primary types are on-body injectors and off-body injectors. On-body injectors are drug delivery devices attached directly to the patient's skin, typically on the abdomen or the back of the patient's arm. They find applications in various medical fields, including immuno-oncology, diabetes, cardiovascular diseases, among others, and are employed across a range of healthcare settings, including hospitals, clinics, and home care.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The wearable injectors market research report is one of a series of new reports from The Business Research Company that provides wearable injectors market statistics, including wearable injectors industry global market size, regional shares, competitors with a wearable injectors market share, detailed wearable injectors market segments, market trends and opportunities, and any further data you may need to thrive in the wearable injectors industry. This wearable injectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wearable injectors market size has grown rapidly in recent years. It will grow from $8.84 billion in 2024 to $9.84 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to chronic disease management, patient convenience, technological advancements, aging population.

The wearable injectors market size is expected to see rapid growth in the next few years. It will grow to $17.2 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to personalized medicine, remote patient monitoring, drug development, chronic disease management. Major trends in the forecast period include biologics and large molecules, dual-chamber wearables, connected and smart devices, patch pump technology.

The forecast of 15.0% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for needle-free delivery mechanisms and drug cartridge assemblies, sourced from key regions such as India and Mexico, could lead to higher prices for self-administered biologic therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rise in the prevalence of chronic conditions such as diabetes, cardiovascular diseases, and cancers has significantly contributed to the growth of the wearable injectors market. For example, in April 2023, a report from the British Diabetic Association, a UK-based charity supporting individuals with diabetes, highlighted that approximately 4.3 million people in the UK are diagnosed with diabetes. Of these, around 90% have type 2 diabetes, about 8% are diagnosed with type 1 diabetes, and the remaining 2% have other forms of diabetes. The increasing number of patients with diabetes and other chronic conditions has led to a greater demand for treatment solutions, driving the expansion of the wearable injectors market.

The increasing elderly population is expected to be a driving force behind the growth of the wearable injectors market in the future. This demographic consists of older adults, typically aged 65 and above, and wearable injectors offer them a convenient way to self-administer medications, fostering independence and adherence to treatment regimens while reducing the necessity for frequent hospital visits. For example, in October 2022, the World Health Organization reported that globally, one in six individuals would be 60 years old or older by 2030, and it is projected that there will be 2.1 billion elderly individuals by 2050. Hence, the growing geriatric population is a key driver of the wearable injectors market's expansion.

Many companies in the wearable injectors manufacturing market are focusing on developing advanced products such as on-body injectors (OBI) to enhance patient convenience, improve adherence to prescribed treatments, and meet the rising demand for self-administration of biologics. An On-Body Injector (OBI) is a wearable drug delivery device designed to administer medications subcutaneously over a specific period, providing convenience for patients who require large-volume or timed-dose injections. For example, in February 2024, Coherus BioSciences Inc., a US-based biotechnology company, launched UDENYCA, an advanced drug delivery device using the LTS Sorrel wearable platform. This device is designed to administer pegfilgrastim-cbqv, a biosimilar of pegfilgrastim, used the day after chemotherapy to reduce the risk of febrile neutropenia, a condition marked by fever and low white blood cell count due to infections. The OBI ensures precise dosing and convenience by enabling at-home administration, removing the need for additional clinic visits.

Major players in the wearable injectors market are increasingly focusing on introducing innovative medication delivery devices like the enFuse injector to enhance their revenue in the market. The enFuse injector is designed for the self-administration of high-volume drugs, offering patients comfort and convenience. For instance, in September 2023, Enable Injections, Inc., a US-based medical technology company, obtained approval from the US Food and Drug Administration (FDA) for the enFuse injector. This wearable injector is intended for the subcutaneous delivery of EMPAVELI, a medication used by adults with paroxysmal nocturnal hemoglobinuria (PNH) and marketed in the United States by Apellis Pharmaceuticals Inc. The enFuse injector is a compact, wearable device that simplifies the self-administration process with minimal disruption to patients' daily routines. It enables hands-free delivery of up to 25 mL, making it suitable for use at home or in clinical settings. The FDA approval of the enFuse injector provides patients with a more convenient way to administer their medication.

In June 2023, LTS LOHMANN Therapie-Systeme AG, a pharmaceutical company based in Germany, purchased the Sorrel wearable injection device business from Eitan Medical for an undisclosed sum. This acquisition is anticipated to broaden LTS LOHMANN Therapie-Systeme AG's range of drug delivery platforms and enhance its offerings in the areas of large molecules and biologics. Eitan Medical Ltd. is an Israeli medical device company known for its development of innovative drug delivery solutions, including wearable injectors.

Major companies operating in the wearable injectors market include Amgen Inc., Becton Dickinson and Company (BD), Enable Injections LLC, Insulet Corporation, Ypsomed Holding AG, Medtronic MiniMed Inc., Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., Sensile Medical AG, Gerresheimer AG, Dexcom Inc., Consort Medical PLC, United Therapeutics Corporation, Buhler Motor GmbH, Debiotech SA, Cellnovo Group, EoFlow Co. Ltd., CeQur SA, Haselmeier AG, Johnson & Johnson, kaleo Inc., Mylan N.V., Nemera Development S.A., F. Hoffmann-La Roche Ltd., Zosano Pharma Corporation

North America was the largest region in the wearable injectors market in 2024. Western Europe was the second-largest region in the wearable injectors market analysis. The regions covered in the wearable injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the wearable injectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The wearable injectors market consists of sales of instruments such as on-body injectors and off-body injectors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wearable Injectors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wearable injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for wearable injectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The wearable injectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: On-Body Injectors; Off-Body Injectors
  • 2) By End-User: Hospitals; Clinics; Homecare setting
  • 3) By Application: Immuno-Oncology; Diabetes; Cardiovascular Diseases; Other Applications
  • Subsegments:
  • 1) By On-Body Injectors: Patch-Based Injectors; Adhesive-Based Injectors; Needle-Based Injectors; Needle-Free Injectors
  • 2) By Off-Body Injectors: Belt-Based Injectors; Handheld Injectors; Clip-Based Injectors
  • Companies Mentioned: Amgen Inc.; Becton Dickinson and Company (BD); Enable Injections LLC; Insulet Corporation; Ypsomed Holding AG; Medtronic MiniMed Inc.; Tandem Diabetes Care Inc.; Valeritas Inc.; West Pharmaceutical Services Inc.; Sensile Medical AG; Gerresheimer AG; Dexcom Inc.; Consort Medical plc; United Therapeutics Corporation; Buhler Motor GmbH; Debiotech SA; Cellnovo Group; EoFlow Co. Ltd.; CeQur SA; Haselmeier AG; Johnson & Johnson; kaleo Inc.; Mylan N.V.; Nemera Development S.A.; F. Hoffmann-La Roche Ltd; Zosano Pharma Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Wearable Injectors Market Characteristics

3. Wearable Injectors Market Trends And Strategies

4. Wearable Injectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Wearable Injectors Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Wearable Injectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Wearable Injectors Market Growth Rate Analysis
  • 5.4. Global Wearable Injectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Wearable Injectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Wearable Injectors Total Addressable Market (TAM)

6. Wearable Injectors Market Segmentation

  • 6.1. Global Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Body Injectors
  • Off-Body Injectors
  • 6.2. Global Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare setting
  • 6.3. Global Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immuno-Oncology
  • Diabetes
  • Cardiovascular Diseases
  • Other Applications
  • 6.4. Global Wearable Injectors Market, Sub-Segmentation Of On-Body Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patch-Based Injectors
  • Adhesive-Based Injectors
  • Needle-Based Injectors
  • Needle-Free Injectors
  • 6.5. Global Wearable Injectors Market, Sub-Segmentation Of Off-Body Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Belt-Based Injectors
  • Handheld Injectors
  • Clip-Based Injectors

7. Wearable Injectors Market Regional And Country Analysis

  • 7.1. Global Wearable Injectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Wearable Injectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Wearable Injectors Market

  • 8.1. Asia-Pacific Wearable Injectors Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Wearable Injectors Market

  • 9.1. China Wearable Injectors Market Overview
  • 9.2. China Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Wearable Injectors Market

  • 10.1. India Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Wearable Injectors Market

  • 11.1. Japan Wearable Injectors Market Overview
  • 11.2. Japan Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Wearable Injectors Market

  • 12.1. Australia Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Wearable Injectors Market

  • 13.1. Indonesia Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Wearable Injectors Market

  • 14.1. South Korea Wearable Injectors Market Overview
  • 14.2. South Korea Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Wearable Injectors Market

  • 15.1. Western Europe Wearable Injectors Market Overview
  • 15.2. Western Europe Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Wearable Injectors Market

  • 16.1. UK Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Wearable Injectors Market

  • 17.1. Germany Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Wearable Injectors Market

  • 18.1. France Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Wearable Injectors Market

  • 19.1. Italy Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Wearable Injectors Market

  • 20.1. Spain Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Wearable Injectors Market

  • 21.1. Eastern Europe Wearable Injectors Market Overview
  • 21.2. Eastern Europe Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Wearable Injectors Market

  • 22.1. Russia Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Wearable Injectors Market

  • 23.1. North America Wearable Injectors Market Overview
  • 23.2. North America Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Wearable Injectors Market

  • 24.1. USA Wearable Injectors Market Overview
  • 24.2. USA Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Wearable Injectors Market

  • 25.1. Canada Wearable Injectors Market Overview
  • 25.2. Canada Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Wearable Injectors Market

  • 26.1. South America Wearable Injectors Market Overview
  • 26.2. South America Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Wearable Injectors Market

  • 27.1. Brazil Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Wearable Injectors Market

  • 28.1. Middle East Wearable Injectors Market Overview
  • 28.2. Middle East Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Wearable Injectors Market

  • 29.1. Africa Wearable Injectors Market Overview
  • 29.2. Africa Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Wearable Injectors Market Competitive Landscape And Company Profiles

  • 30.1. Wearable Injectors Market Competitive Landscape
  • 30.2. Wearable Injectors Market Company Profiles
    • 30.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Enable Injections LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Ypsomed Holding AG Overview, Products and Services, Strategy and Financial Analysis

31. Wearable Injectors Market Other Major And Innovative Companies

  • 31.1. Medtronic MiniMed Inc.
  • 31.2. Tandem Diabetes Care Inc.
  • 31.3. Valeritas Inc.
  • 31.4. West Pharmaceutical Services Inc.
  • 31.5. Sensile Medical AG
  • 31.6. Gerresheimer AG
  • 31.7. Dexcom Inc.
  • 31.8. Consort Medical plc
  • 31.9. United Therapeutics Corporation
  • 31.10. Buhler Motor GmbH
  • 31.11. Debiotech SA
  • 31.12. Cellnovo Group
  • 31.13. EoFlow Co. Ltd.
  • 31.14. CeQur SA
  • 31.15. Haselmeier AG

32. Global Wearable Injectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Wearable Injectors Market

34. Recent Developments In The Wearable Injectors Market

35. Wearable Injectors Market High Potential Countries, Segments and Strategies

  • 35.1 Wearable Injectors Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Wearable Injectors Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Wearable Injectors Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer